Found: 17
Select item for more details and to access through your institution.
Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects.
- Published in:
- Pharmacology Research & Perspectives, 2018, v. 6, n. 1, p. 1, doi. 10.1002/prp2.380
- By:
- Publication type:
- Article
Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies.
- Published in:
- Drugs in R&D, 2016, v. 16, n. 1, p. 81, doi. 10.1007/s40268-015-0118-4
- By:
- Publication type:
- Article
Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients.
- Published in:
- Drugs in R&D, 2012, v. 12, n. 3, p. 127, doi. 10.2165/11634360-000000000-00000
- By:
- Publication type:
- Article
Ipecacuanha-induced emesis: A human model for testing antiemetic drug activity.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 1, p. 53, doi. 10.1038/clpt.1993.109
- By:
- Publication type:
- Article
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL‐286, a novel retinoic acid receptor‐β agonist for treatment of spinal cord injury, in male healthy participants.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 12, p. 3573, doi. 10.1111/bcp.15854
- By:
- Publication type:
- Article
Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira<sup>®</sup> in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 4, p. 983, doi. 10.1111/bcp.13039
- By:
- Publication type:
- Article
Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 1, p. 78, doi. 10.1111/bcp.12048
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, p. 1, doi. 10.1186/s13075-015-0797-9
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0797-9
- By:
- Publication type:
- Article
Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 6, p. 701, doi. 10.1007/s00228-018-2435-3
- By:
- Publication type:
- Article
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 3, p. 195, doi. 10.1007/s40256-015-0117-4
- By:
- Publication type:
- Article
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 2, p. 194, doi. 10.1002/jcph.794
- By:
- Publication type:
- Article
Maximum Tolerated Dose and Pharmacodynamics of Eptastigmine in Elderly Healthy Volunteers.
- Published in:
- 1998
- By:
- Publication type:
- Other
Effect of Oral Posaconazole on the Pharmacokinetics of Cyclosporine and Tacrolimus.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 6, p. 825, doi. 10.1592/phco.27.6.825
- By:
- Publication type:
- Article
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair.
- Published in:
- Frontiers in Molecular Neuroscience, 2024, p. 1, doi. 10.3389/fnmol.2024.1411384
- By:
- Publication type:
- Article
Is there a role of synovial biopsy in drug development?
- Published in:
- 2016
- By:
- Publication type:
- journal article